RELX RELX PLC Q2 2025 EPS narrowly tops estimates shares gain 034 percent in todays trading Is Forte Biosciences FBRX stock respecting technical levels Q4 2025 Earnings Fall Short INTU Intuit delivers 11 percent Q1 2026 EPS beat shares gain 33 percent on strong investor sentiment Gilead Sciences GILD Arcellx Acquisition Clearance and Bullish Analyst Upgrade Underpin NearTerm Upside Catalysts ASPCR A SPAC III publishes latest quarterly earnings remains focused on identifying viable deSPAC merger targets